Delivery Order SPE2DB22D1017-SPE2DB25FYRQC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units, with a ceiling value of $2,021.12. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a ceiling value of $1,038.82. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and has an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with a contract ceiling value of $3,248.74. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $2,694.99 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (immediate release) in quantities of 100 units. The contract, awarded on September 24, 2025, carries a firm fixed price structure with an ultimate completion date of September 25, 2025, and is not designated as a set-aside contract. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,009.52 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release formulation) in quantities of 100 units. The award, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, carries a firm fixed price and represents a competitively awarded, non-set-aside contract. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.80 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (100 count) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single shipment of this immunosuppressant medication, which is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,929.51 for Tacrolimus 5 mg capsules (immediate-release formulation, 100-count units) on December 9, 2025, with an ultimate completion date of December 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,135.63 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units. The contract, awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, is classified as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units, with a ceiling value of $1,654.65. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and is classified as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $6,951.06 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with an ultimate completion date of May 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRQCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Tacrolimus 1 mg capsules (immediate-release formulation) in quantities of 100 units at a ceiling value of $1,671.70. This is a firm fixed-price delivery order with a completion date of September 23, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement processes. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, supplying medications and medical commodities across therapeutic domains to support military healthcare systems worldwide. The firm has demonstrated consistent capability to fulfill federal pharmaceutical requirements through multiple competitively awarded contracts with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/22/25 |